Advertisement

Inflammation

  • Abdelhamid H. Elgazzar
  • Ismet Sarikaya
Chapter

Abstract

In-111 leukocyte (white blood cell—WBC) imaging is mainly used to diagnose various acute infections, particularly in musculoskeletal system (osteomyelitis in areas other than the spine). It is also used to diagnose infected vascular grafts, infected central venous catheters or other devices, fever of unknown origin (FUO), postoperative abscesses, inflammatory bowel disease, lung infections, endocarditis, and neurological infections.

References

  1. 1.
    Society of Nuclear Medicine Procedure Guideline for 111In-Leukocyte Scintigraphy for Suspected Infection/Inflammation Version 3.0, approved June 2, 2004Google Scholar
  2. 2.
    Palestro CJ, Love C (2007) Radionuclide imaging of musculoskeletal infection: conventional agents. Semin Musculoskelet Radiol 11:335–352CrossRefPubMedGoogle Scholar
  3. 3.
    Bar-Shalom R, Yefremov N, Guralnik L, Keidar Z, Engel A et al (2006) SPECT/CT using 67Ga and 111In-labeled leukocyte scintigraphy for diagnosis of infection. J Nucl Med 47:587–594PubMedGoogle Scholar
  4. 4.
    Nasseri F, Bhargava P (2012) Prosthesis-related abscess on In-111 leukocyte SPECT/CT imaging. Nucl Med Mol Imaging 46:76–77CrossRefPubMedGoogle Scholar
  5. 5.
    Heiba SI, Kolker D, Mocherla B, Kapoor K, Jiang M et al (2010) The optimized evaluation of diabetic foot infection by dual isotope SPECT/CT imaging protocol. J Foot Ankle Surg 49:529–536CrossRefPubMedGoogle Scholar
  6. 6.
    Nasu R, Akagi K, Murata T, Uokawa K, Isoda H et al (1998) In-111 labeled leukocyte scintigraphy in patients with suspected inflammation after failed antibiotic therapy. Radiat Med 16:347–351PubMedGoogle Scholar
  7. 7.
    Society of Nuclear Medicine Procedure Guideline for Tc-99m Exametazime (HMPAO) Labeled Leukocyte Scintigraphy for Suspected Infection/Inflammation version 2.0, approved February 7, 1999Google Scholar
  8. 8.
    de Vries EF, Roca M, Jamar F, Israel O, Signore A (2010) Guidelines for the labelling of leucocytes with (99m)Tc-HMPAO. Inflammation/Infection Task group of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging 37:842–848CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Palestro CJ, Love C, Tronco GG, Tomas MB, Rini JN (2006) Combined labeled leukocyte and technetium 99m sulfur colloid bone marrow imaging for diagnosing musculoskeletal infection. Radiographics 26:859–870CrossRefPubMedGoogle Scholar
  10. 10.
    Filippi L, Schillaci O (2006) Usefulness of hybrid SPECT/CT in 99mTc-HMPAO-labeled leukocyte scintigraphy for bone and joint infections. J Nucl Med 47:1908–1913PubMedGoogle Scholar
  11. 11.
    Djekidel M, Brown RK, Piert M (2011) Benefits of hybrid SPECT/CT for (111)In-oxine- and Tc-99m-hexamethylpropylene amine oxime-labeled leukocyte imaging. Clin Nucl Med 36:50–56CrossRefGoogle Scholar
  12. 12.
    Hughes DK (2003) Nuclear medicine and infection detection: the relative effectiveness of imaging with 111In-oxine-, 99mTc-HMPAO-, and 99mTc-stannous fluoride colloid-labeled leukocytes and with 67Ga-citrate. J Nucl Med Technol 31:196–201PubMedGoogle Scholar
  13. 13.
    Glaudemans AW, Galli F, Pacilio M, Signore A (2013) Leukocyte and bacteria imaging in prosthetic joint infection. Eur Cell Mater 25:61–77CrossRefPubMedGoogle Scholar
  14. 14.
    Hoffer P (1980) Gallium: mechanisms. J Nucl Med 21:282–285PubMedGoogle Scholar
  15. 15.
    Sephton R, Martin JJ (1980) Modification of distribution of gallium-67 in man by administration of iron. Br J Radiol 53:572–575CrossRefPubMedGoogle Scholar
  16. 16.
    Hattner RS, White DL (1990) Gallium-67/stable gadolinium antagonism: MRI contrast agent markedly alters the normal biodistribution of Gallum-67. J Nucl Med 31:1844–1846PubMedGoogle Scholar
  17. 17.
    Seabold JE, Palestro CJ, Brown ML, Datz FL, Forstrom LA et al (1997) Procedure guideline for gallium scintigraphy in inflammation. Society of Nuclear Medicine. J Nucl Med 38:994–997PubMedGoogle Scholar
  18. 18.
    Palestro CJ (1994) The current role of gallium imaging in infection. Semin Nuc Med 14:128–141CrossRefGoogle Scholar
  19. 19.
    Quigley AM, Gnanasegaran G, Buscombe JR, Hilson AJ (2008) Technetium-99m-labelled sulesomab (LeukoScan) in the evaluation of soft tissue infections. Med Princ Pract 17:447–452CrossRefPubMedGoogle Scholar
  20. 20.
    Rubello D, Rampin L, Banti E, Grassetto G, Massaro A et al (2008) Antigranulocyte scintigraphy in infected hip prosthesis: the diagnostic importance delayed 20-24-h imaging and semiquantitative analysis. Nucl Med Commun 29:994–998CrossRefPubMedGoogle Scholar
  21. 21.
    Gratz S, Schipper ML, Dorner J, Höffken H, Becker W et al (2003) LeukoScan for imaging infection in different clinical settings: a retrospective evaluation and extended review of the literature. Clin Nucl Med 28:267–276PubMedGoogle Scholar
  22. 22.
    Devillers A, Garin E, Polard JL, Poirier JY, Arvieux C et al (2000) Comparison of Tc-99m-labelled antileukocyte fragment Fab’ and Tc-99m-HMPAO leukocyte scintigraphy in the diagnosis of bone and joint infections: a prospective study. Nucl Med Commun 21:747–753CrossRefPubMedGoogle Scholar
  23. 23.
    Kerry JE, Marshall C, Griffiths PA, James MW, Scott BB (2005) Comparison between Tc-HMPAO labelled white cells and Tc LeukoScan in the investigation of inflammatory bowel disease. Nucl Med Commun 26:245–251CrossRefPubMedGoogle Scholar
  24. 24.
    Jamar F, Buscombe J, Chiti A, Christian PE, Delbeke D et al (2013) EANM/SNMMI guideline for 18F-FDG use in inflammation and infection. J Nucl Med 54:647–658CrossRefPubMedGoogle Scholar
  25. 25.
    Blockmans D, de Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L et al (2006) Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum 55:131–137CrossRefPubMedGoogle Scholar
  26. 26.
    Rabkin Z, Israel O, Keidar Z (2010) Do hyperglycemia and diabetes affect the incidence of false-negative 18F-FDG PET/CT studies in patients evaluated for infection or inflammation and cancer? A comparative analysis. J Nucl Med 51:1015–1020CrossRefPubMedGoogle Scholar
  27. 27.
    Annovazzi A, Bagni B, Burroni L, D’Alessandria C, Signore A (2005) Nuclear medicine imaging of inflammatory/infective disorders of the abdomen. Nucl Med Commun 26:657–664CrossRefPubMedGoogle Scholar
  28. 28.
    Ingui CJ, Shah NP, Oates ME (2007) Infection scintigraphy: added value of single-photon emission computed tomography/computed tomography fusion compared with traditional analysis. J Comput Assist Tomogr 31:375–380CrossRefPubMedGoogle Scholar
  29. 29.
    Caobelli F, Panarotto MB, Andreoli F, Ravelli A, De Agostini A et al (2011) Is 99mTc-HMPAO granulocyte scan an alternative to endoscopy in pediatric chronic inflammatory bowel disease (IBD)? Eur J Pediatr 170:51–57CrossRefPubMedGoogle Scholar
  30. 30.
    Meller J, Sahlmann CO, Scheel AK (2007) 18F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med 48:35–45PubMedGoogle Scholar
  31. 31.
    Stumpe KD, Dazzi H, Schaffner A, von Schulthess GK (2000) Infection imaging using whole-body FDG PET. Eur J Nucl Med 27:822–832CrossRefPubMedGoogle Scholar
  32. 32.
    Bleeker-Rovers CP, deKleijn EM, Corstens FH, van der Meer JW, Oyen WJ (2004) Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging 31:29–37CrossRefPubMedGoogle Scholar
  33. 33.
    Schroeder T, Melo MF, Venegas JG (2011) Analysis of 2-[Fluorine-18]-Fluoro-2-deoxy-D-glucose uptake kinetics in PET studies of pulmonary inflammation. Acad Radiol 18:418–423CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Gupta SM, Sziklas JJ, Spencer RP, Rosenberg R (1980) Significance of diffuse pulmonary uptake in radio gallium scans: concise communication. J Nucl Med 21:328–332PubMedPubMedCentralGoogle Scholar
  35. 35.
    Charron M, Ackerman ES, Kolodny GM, Rosenthall L (1988) Focal lung uptake of gallium-67 in patients with acquired immunodeficiency syndrome secondary to pneumocystis carinii pneumonia. Eur J Nucl Med 14:424–426PubMedGoogle Scholar
  36. 36.
    Kono M, Yamashita H, Kubota K, Kano T, Mimori A (2015) FDG PET imaging in pneumocystis pneumonia. Clin Nucl Med 40:679–681CrossRefPubMedGoogle Scholar
  37. 37.
    Huang CJ, You DL, Lee PI, Hsu LH, Liu CC et al (2009) Characteristics of integrated 18F-FDG PET/CT in pulmonary cryptococcosis. Acta Radiol 50:374–378CrossRefPubMedGoogle Scholar
  38. 38.
    Bakheet SM, Powe J, Ezzat A, Rostom A (1998) F-18-FDG uptake in tuberculosis. Clin Nucl Med 23:739–742CrossRefPubMedGoogle Scholar
  39. 39.
    Güngör T, Engel-Bicik I, Eich G, Willi UV, Nadal D et al (2001) Diagnostic and therapeutic impact of whole body positron emission tomography using fluorine-18-fluoro-2-deoxy-D-glucose in children with chronic granulomatous disease. Arch Dis Child 85:341–345CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Hardoff R, Gips S, Uri N, Front A, Tamir A (1994) Semiquantitative skull planar and SPECT bone scintigraphy in diabetic patients: differentiation of necrotizing (malignant) external otitis from severe external otitis. J Nucl Med 35:411–415PubMedGoogle Scholar
  41. 41.
    Stokkel MP, Boot CN, van Eck-Smit BL (1996) SPECT gallium scintigraphy in malignant external otitis: initial staging and follow-up. Case reports. Laryngoscope 106:338–340CrossRefPubMedGoogle Scholar
  42. 42.
    Sheng JF, Sheng ZK, Shen XM, Bi S, Li JJ et al (2011) Diagnostic value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with fever of unknown origin. Eur J Intern Med 22:112–116CrossRefPubMedGoogle Scholar
  43. 43.
    Keidar Z, Gurman-Balbir A, Gaitini D, Israel O (2008) Fever of unknown origin: the role of 18F-FDG PET/CT. J Nucl Med 49:1980–1985CrossRefPubMedGoogle Scholar
  44. 44.
    Crouzet J, Boudousq V, Lechiche C, Pouget JP, Kotzki PO et al (2012) Place of (18)F-FDG-PET with computed tomography in the diagnostic algorithm of patients with fever of unknown origin. Eur J Clin Microbiol Infect Dis 31:1727–1733CrossRefPubMedGoogle Scholar
  45. 45.
    Balink H, Collins J, Bruyn GA, Gemmel F (2009) F-18 FDG PET/CT in the diagnosis of fever of unknown origin. Clin Nucl Med 34:862–868CrossRefPubMedGoogle Scholar
  46. 46.
    Lee VW, Fuller JD, O'Brien MJ, Parker DR, Cooley TP et al (1991) Pulmonary Kaposi sarcoma in patients with AIDS: scintigraphic diagnosis with sequential thallium and gallium scanning. Radiology 180:409–412CrossRefPubMedGoogle Scholar
  47. 47.
    Palestro CJ, Goldsmith SJ (1995) The role of gallium and labeled leukocyte scintigraphy in the AIDS patient. Q J Nucl Med 39:221–230PubMedGoogle Scholar
  48. 48.
    Köhn H, Armbruster C, König B, Vetter N, Mostbeck A (1993) Contribution of nuclear medicine to management of pulmonary complications in patients with acquired immune deficiency. Acta Med Austriaca 20:36–41PubMedGoogle Scholar
  49. 49.
    Ruiz A, Ganz WI, Post MJ, Camp A, Landy H et al (1994) Use of thallium-201 brain SPECT to differentiate cerebral lymphoma from toxoplasma encephalitis in AIDS patients. AJNR Am J Neuroradiol l15:1885–1894Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Abdelhamid H. Elgazzar
    • 1
  • Ismet Sarikaya
    • 1
  1. 1.Department of Nuclear MedicineKuwait UniversitySafatKuwait

Personalised recommendations